Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-18.21	968.12	1183.68
Graham Fair Price	114.48	3.43	1.60
PEG	-89.94	-0.03	0.29
Price/Book	-9.55	0.47	0.51
Price/Cash Flow	103.42	-7.88	3.88
Prices/Earnings	76.89	-9.52	-41.21
Price/Sales	197.16	-37.97	12.78
Price/FCF	103.42	-7.88	3.88
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-21.03	-0.79	1.00
Operating Margin	1260.38	1.37	-0.10
ROA	-268.61	< 0.005	< 0.005
ROE	< 0.005	-0.01	-291.30
ROIC	< 0.005	< 0.005	-154.62
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.05	0.25	-78.69
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.15	-3.17	-175.44
EPS QOQ	-1.41	-3.23	-129.86
FCF QOQ	-0.82	-1.45	-75.89
Revenue QOQ	< 0.005	-1.31	14178.72
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.63	0.62	-2.27
Quick Ratio	1.97	1.76	-10.83
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.04	6.55	8.43
Cash	16.89	20.93	23.95
Capex	-0.02	-0.01	42.53
Free Cash Flow	0.80	-0.39	-51.79
Revenue	0.24	-0.08	-67.00
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.85	2.44	-14.46
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	889.95	715.40	-19.61
Naive Interpretation	Member

06 - Financial Health · Bad

Rating